Tamara Didishvili
Boston University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tamara Didishvili.
Circulation Research | 2004
Victoria L. M. Herrera; Tamara Didishvili; Lyle V. Lopez; Richard H. Myers; Nelson Ruiz-Opazo
Abstract— Hypercholesterolemia is a significant risk factor for coronary artery disease development. Genes influencing nonmonogenic hypercholesterolemia susceptibility in humans remain to be identified. Animal models are key investigative systems because major confounding variables such as diet, activity, and genetic background can be controlled. We performed a 121-marker, total genome-analysis of an F2[Dahl R×S]-intercross selected for contrasting parental strain susceptibilities for hyperlipidemia on regular rat diets at 6 months of age. Quantitative traits studied were plasma total cholesterol, triglyceride, HDL, and LDL levels adjusted for obesity. Genome-wide analysis of 200 F2-intercross male rats detects two QTLs with highly significant linkage for total cholesterol (TC) on chromosome (chr) 5−133.3 Mbp (LOD 5.8), and chr5−54.2 Mbp (LOD 4.8), and two QTLs with significant linkage for TC: on chromosome 8, chr8−60.4 Mbp (LOD 3.8), and chromosome 2, chr2−243.5 Mbp (LOD 3.4). A QTL for LDL with significant linkage is detected on chromosome 5, chr5−104 Mbp (LOD 3.7). These QTLs contribute from 7% to 12% of total trait variance, respectively, with Dahl-S allele effects resulting in increased TC and LDL levels consistent with hyperlipidemia susceptibility in the parental Dahl-S rat strain. Predicted QTL-peaks do not coincide with previous genome scans. Human homologues of two TC-QTLs span genes listed in a LocusLink profile for cholesterol. Only suggestive loci were detected for HDL and total triglyceride levels. Altogether, the data demonstrates the contribution of multiple QTLs to hypercholesterolemia making a multipathway pathogenic framework imperative. QTL-peak candidate genes delineated are syntenic between rat and human genomes, increasing clinical relevance and mandating further study.
PLOS ONE | 2013
Nicola Glorioso; Victoria L. M. Herrera; Tamara Didishvili; Maria Francesca Ortu; Roberta Zaninello; Giovanni Fresu; Giuseppe Argiolas; Chiara Troffa; Nelson Ruiz-Opazo
Coronary artery disease, heart failure, fatal arrhythmias, stroke, and renal disease are the most common causes of mortality for humans, and essential hypertension remains a major risk factor. Elucidation of susceptibility loci for essential hypertension has been difficult because of its complex, multifactorial nature involving genetic, environmental, and sex- and age-dependent nature. We investigated whether the 11p15.5 region syntenic to rat chromosome 1 region containing multiple blood pressure quantitative trait loci (QTL) detected in Dahl rat intercrosses harbors polymorphisms that contribute to susceptibility/resistance to essential hypertension in a Sardinian population. Initial testing performed using microsatellite markers spanning 18 Mb of 11p15.5 detected a strong association between D11S1318 (at 2.1 Mb, P = 0.004) and D11S1346 (at 10.6 Mb, P = 0.00000004), suggesting that loci in close proximity to these markers may contribute to susceptibility in our Sardinian cohort. NLR family, pyrin domain containing 6/angiotensin-vasopressin receptor (NLRP6/AVR), and adrenomedullin (ADM) are in close proximity to D11S1318 and D11S1346, respectively; thus we tested single nucleotide polymorphisms (SNPs) within NLRP6/AVR and ADM for their association with hypertension in our Sardinian cohort. Upon sex stratification, we detected one NLRP6/AVR SNP associated with decreased susceptibility to hypertension in males (rs7948797G, P = 0.029; OR = 0.73 [0.57–0.94]). For ADM, sex-specific analysis showed a significant association between rs4444073C, with increased susceptibility to essential hypertension only in the male population (P = 0.006; OR = 1.44 [1.13–1.84]). Our results revealed an association between NLRP6/AVR and ADM loci with male essential hypertension, suggesting the existence of sex-specific NLRP6/AVR and ADM variants affecting male susceptibility to essential hypertension.
Molecular Medicine | 2001
Victoria L. M. Herrera; Tamara Didishvili; Lyle V. Lopez; Kimberly Zander; Sarah Traverse; Donald L. Gantz; Haya Herscovitz; Nelson Ruiz-Opazo
Physiological Genomics | 2005
Yuji Kaneko; Victoria L. M. Herrera; Tamara Didishvili; Nelson Ruiz-Opazo
Molecular Medicine | 2003
Victoria L. M. Herrera; Li Shen; Lyle V. Lopez; Tamara Didishvili; You-Xun Zhang; Nelson Ruiz-Opazo
Atherosclerosis | 2004
Victoria L. M. Herrera; Aristides Tsikoudakis; Tamara Didishvili; Lorenz R. B. Ponce; Pia Bagamasbad; Donald L. Gantz; Haya Herscovitz; Arie van Tol; Nelson Ruiz-Opazo
Physiological Genomics | 2005
Victoria L. M. Herrera; Lorenz R. B. Ponce; Pia Bagamasbad; Benjamin D. VanPelt; Tamara Didishvili; Nelson Ruiz-Opazo
Molecular Medicine | 2002
Victoria L. M. Herrera; Tamara Didishvili; Lyle V. Lopez; Nelson Ruiz-Opazo
Physiological Genomics | 2008
Victoria L. M. Herrera; Pia Bagamasbad; Tamara Didishvili; Julius L. Decano; Nelson Ruiz-Opazo
Physiological Genomics | 2011
Nicola Glorioso; Victoria L. M. Herrera; Tamara Didishvili; Giuseppe Argiolas; Chiara Troffa; Patrizia Bulla; Emanuela Bulla; Nelson Ruiz-Opazo